Representative coexpressed gene network |
KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
hsa05133 |
Pertussis |
41 |
|
hsa05417 |
Lipid and atherosclerosis |
23 |
|
hsa05171 |
Coronavirus disease - COVID-19 |
21 |
|
hsa05152 |
Tuberculosis |
19 |
|
hsa05142 |
Chagas disease |
19 |
|
|
KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
mmu05133 |
Pertussis |
47 |
|
mmu05417 |
Lipid and atherosclerosis |
33 |
|
mmu05171 |
Coronavirus disease - COVID-19 |
27 |
|
mmu05152 |
Tuberculosis |
26 |
|
mmu04625 |
C-type lectin receptor signaling pathway |
25 |
|
|
KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
rno05133 |
Pertussis |
44 |
|
rno05417 |
Lipid and atherosclerosis |
23 |
|
rno05171 |
Coronavirus disease - COVID-19 |
22 |
|
rno04936 |
Alcoholic liver disease |
20 |
|
rno05152 |
Tuberculosis |
20 |
|
|
KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
mcc05133 |
Pertussis |
41 |
|
mcc05171 |
Coronavirus disease - COVID-19 |
25 |
|
mcc05142 |
Chagas disease |
20 |
|
mcc05417 |
Lipid and atherosclerosis |
20 |
|
mcc05135 |
Yersinia infection |
18 |
|
|
KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
cfa05133 |
Pertussis |
38 |
|
cfa05171 |
Coronavirus disease - COVID-19 |
20 |
|
cfa05417 |
Lipid and atherosclerosis |
20 |
|
cfa05142 |
Chagas disease |
18 |
|
cfa05200 |
Pathways in cancer |
18 |
|
|
KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
fca05133 |
Pertussis |
35 |
|
fca05171 |
Coronavirus disease - COVID-19 |
23 |
|
fca05142 |
Chagas disease |
19 |
|
fca05152 |
Tuberculosis |
18 |
|
fca05417 |
Lipid and atherosclerosis |
18 |
|
|
Gene list in the network |
|
|
Symbol |
Function* |
|
Actb |
actin, beta |
|
Aif1 |
allograft inflammatory factor 1 |
|
Rhoa |
ras homolog family member A |
|
Atf3 |
activating transcription factor 3 |
|
Serping1 |
serine (or cysteine) peptidase inhibitor, clade G, member 1 |
|
C1qa |
complement component 1, q subcomponent, alpha polypeptide |
|
C1qb |
complement component 1, q subcomponent, beta polypeptide |
|
C1qc |
complement component 1, q subcomponent, C chain |
|
C2 |
complement component 2 (within H-2S) |
|
C3 |
complement component 3 |
|
C4b |
complement component 4B (Chido blood group) |
|
Calm1 |
calmodulin 1 |
|
Calm2 |
calmodulin 2 |
|
Calm3 |
calmodulin 3 |
|
Casp1 |
caspase 1 |
|
Casp12 |
caspase 12 |
|
Cd14 |
CD14 antigen |
|
Cfl1 |
cofilin 1, non-muscle |
|
Cfl2 |
cofilin 2, muscle |
|
Cp |
ceruloplasmin |
|
Csf1r |
colony stimulating factor 1 receptor |
|
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
Adgre1 |
adhesion G protein-coupled receptor E1 |
|
Fos |
FBJ osteosarcoma oncogene |
|
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
|
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
|
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
Cfb |
complement factor B |
|
Hpse |
heparanase |
|
Irf8 |
interferon regulatory factor 8 |
|
Il1a |
interleukin 1 alpha |
|
Il1b |
interleukin 1 beta |
|
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
Il6 |
interleukin 6 |
|
Irf1 |
interferon regulatory factor 1 |
|
Itgam |
integrin alpha M |
|
Itgb2 |
integrin beta 2 |
|
Jun |
jun proto-oncogene |
|
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
|
Ly96 |
lymphocyte antigen 96 |
|
Mertk |
MER proto-oncogene tyrosine kinase |
|
Ncf1 |
neutrophil cytosolic factor 1 |
|
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
|
Osm |
oncostatin M |
|
Pfn1 |
profilin 1 |
|
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) |
|
Mapk11 |
mitogen-activated protein kinase 11 |
|
Dusp1 |
dual specificity phosphatase 1 |
|
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
Tlr4 |
toll-like receptor 4 |
|
Tnf |
tumor necrosis factor |
|
Mapk1 |
mitogen-activated protein kinase 1 |
|
Mapk14 |
mitogen-activated protein kinase 14 |
|
Mapk3 |
mitogen-activated protein kinase 3 |
|
Mapk8 |
mitogen-activated protein kinase 8 |
|
Mapk12 |
mitogen-activated protein kinase 12 |
|
C1s1 |
complement component 1, s subcomponent 1 |
|
C1ra |
complement component 1, r subcomponent A |
|
Ptbp2 |
polypyrimidine tract binding protein 2 |
|
Pycard |
PYD and CARD domain containing |
|
Calml3 |
calmodulin-like 3 |
|
Rarres2 |
retinoic acid receptor responder (tazarotene induced) 2 |
|
Vsir |
V-set immunoregulatory receptor |
|
Calm4 |
calmodulin 4 |
|
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
Gpr84 |
G protein-coupled receptor 84 |
|
Il23a |
interleukin 23, alpha subunit p19 |
|
Pla1a |
phospholipase A1 member A |
|
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
|
Hdac10 |
histone deacetylase 10 |
|
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
Kcnk13 |
potassium channel, subfamily K, member 13 |
|
Gm94 |
predicted gene 94 |
|
Ticam2 |
toll-like receptor adaptor molecule 2 |
|
C1rl |
complement component 1, r subcomponent-like |
|
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
Gm14023 |
predicted gene 14023 |
|
|
|
|
|